[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.211.180.70. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Special Topics
October 2002

Cosmetic Uses of Botulinum Neurotoxin Type AAn Overview

Author Affiliations

From Columbia University and the New York Center for Voice and Swallowing Disorders, New York (Dr Blitzer), and the Department of Head and Neck Surgery, University of California, Los Angeles (Dr Binder). Drs Blitzer and Binder have received consultant fees from Allergan Inc, Irvine, Calif, and Dr Blitzer has received research grants from Allergan Inc.

 

From Columbia University and the New York Center for Voice and Swallowing Disorders, New York (Dr Blitzer), and the Department of Head and Neck Surgery, University of California, Los Angeles (Dr Binder). Drs Blitzer and Binder have received consultant fees from Allergan Inc, Irvine, Calif, and Dr Blitzer has received research grants from Allergan Inc.

Arch Facial Plast Surg. 2002;4(4):214-220. doi:

Clostridium botulinum produces 7 serologically distinct toxins that are designated A, B, C, D, E, and F. They all have similar structure (a dichain with a disulfide bond) and a molecular weight of about 150 d. The light chain is a zinc-dependent metalloprotease, in which the substrate is one of the fusion proteins responsible for docking and ultimately exocytosis of the acetylcholine-containing vesicle. Each serotype light chain cleaves a specific residue of one of these proteins, thus preventing the formation of this docking complex and hence, preventing neurotransmitter exocytosis.1-2

First Page Preview View Large
First page PDF preview
First page PDF preview
×